» Authors » Gwangil Kim

Gwangil Kim

Explore the profile of Gwangil Kim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 865
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sung M, Shin S, Kwon C, Kang I, Lee S, Yang S, et al.
Sci Rep . 2025 Jan; 15(1):3654. PMID: 39880870
The recent clinical outcomes of multi-regimen chemotherapy included prolonged survival and a high rate of conversion to surgery in Asian patients with advanced biliary tract cancer. The ability of single-operator...
2.
Hwang S, Woo S, Kang B, Kang H, Kim J, Lee S, et al.
J Hepatol . 2024 Oct; PMID: 39442892
Background & Aims: Recent advances in molecular profiling have enabled the identification of potential therapeutic targets for biliary tract cancer (BTC). However, in patients with BTC, molecular profiling is hindered...
3.
4.
Lee J, Yang S, Kwon C, Kim K, Park S, Jang M, et al.
Acta Biomater . 2024 Mar; 178:137-146. PMID: 38447810
Endoscopic biliary stent insertion has been widely used for the treatment of benign biliary stricture (BBS). Thus, the development of stent materials in the perspectives of structure, mechanical properties, and...
5.
You H, Kim G, Lew H
Graefes Arch Clin Exp Ophthalmol . 2024 Mar; 262(8):2643-2649. PMID: 38446201
Purpose: Dermatochalasis is a common disorder of the elderly, often requiring upper blepharoplasty. Although it is mainly accepted as a process of aging, its clinical and histological findings vary among...
6.
Suh-Yun Joh C, Jeong S, Lee C, Lee H, Lee J, Choi H, et al.
Br J Dermatol . 2023 Aug; 189(5):643-645. PMID: 37590958
No abstract available.
7.
Sang Y, Kim G, Hwang S, Kang H, Chon H
J Clin Transl Hepatol . 2023 Mar; 11(3):747-750. PMID: 36969903
We report a case of a patient with c- amplified hepatocellular carcinoma (HCC) who had a dramatic response to cabozantinib despite being refractory to four previous lines of systemic therapy....
8.
Yang H, Kang B, Ha Y, Lee S, Kim I, Kim H, et al.
JHEP Rep . 2023 Mar; 5(4):100672. PMID: 36866388
Background & Aims: We elucidated the clinical and immunologic implications of serum IL-6 levels in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab and bevacizumab (Ate/Bev). Methods: We prospectively...
9.
Choi S, Kang I, Lee S, Kang B, Cheon J, Kim D, et al.
Surgery . 2022 Nov; 173(2):280-288. PMID: 36435652
Background: This study was conducted to evaluate the clinical feasibility of nab-paclitaxel plus gemcitabine-cisplatin triplet chemotherapy in patients with locally advanced cholangiocarcinoma in real-world practice. Methods: We retrospectively reviewed patients...
10.
Chong Y, Bae J, Kang D, Kim G, Han H
J Pathol Transl Med . 2022 Nov; 56(6):370-382. PMID: 36413980
Background: Digital pathology (DP) using whole slide imaging is a recently emerging game changer technology that can fundamentally change the way of working in pathology. The Digital Pathology Study Group...